🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms concealed alleged dangers that the drug posed to pediatric cognitive development.

The lawsuit arrives a month after Former President Trump publicized an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - throughout gestation and autism in children.

Paxton is filing suit against Johnson & Johnson, which previously sold the medication, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "misled consumers by profiting off of discomfort and pushing pills without regard for the dangers."

The manufacturer asserts there is no credible evidence tying Tylenol to autism spectrum disorder.

"These companies lied for decades, deliberately risking countless individuals to line their pockets," Paxton, a Republican, declared.

The company commented that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the possible consequences that could have on the health of US mothers and children."

On its website, the company also mentioned it had "regularly reviewed the pertinent research and there is insufficient valid information that shows a established connection between consuming paracetamol and autism."

Organizations acting on behalf of medical professionals and healthcare providers concur.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to manage discomfort and fever, which can create major wellness concerns if ignored.

"In over twenty years of investigation on the utilization of acetaminophen in gestation, zero credible investigations has conclusively proven that the use of acetaminophen in any period of gestation causes brain development issues in offspring," the organization commented.

This legal action mentions recent announcements from the Trump administration in arguing the drug is allegedly unsafe.

Last month, Trump raised alarms from medical authorities when he advised pregnant women to "fight like hell" not to use acetaminophen when unwell.

The US Food and Drug Administration then released a statement that doctors should think about restricting the usage of acetaminophen, while also stating that "a causal relationship" between the drug and autism in minors has not been established.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in spring to undertake "extensive scientific investigation" that would identify the origin of autism in a matter of months.

But specialists warned that identifying a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a type of permanent neurological difference and condition that impacts how individuals perceive and interact with the surroundings, and is recognized using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is running for US Senate - asserts the manufacturer and J&J "willfully ignored and attempted to silence the research" around paracetamol and autism.

The lawsuit attempts to require the corporations "remove any marketing or advertising" that claims acetaminophen is reliable for expectant mothers.

The court case parallels the concerns of a group of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in 2022.

The court dismissed the legal action, saying investigations from the family's specialists was inconclusive.